Impact of apolipoprotein(a) phenotypes on long-term renal transplant survival.
The long-term success of renal transplantation is limited because of chronic rejection (CR), which shows histologic parallels to atherosclerosis. Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerosis, but its role in CR has not been investigated. Plasma levels of Lp(a) are determined mainly by the inherited isoform (phenotype) of apolipoprotein(a) [apo(a)] and show an inverse correlation with the molecular weight of apo(a). Apo(a) isoforms were identified in frozen sera of 327 patients who received a renal transplant during 1982 to 1992. Long-term graft survival in recipients with high molecular weight (HMW) or low molecular weight (LMW) apo(a) phenotypes were compared retrospectively. Mean (95% confidence interval) transplant survival was 12.8 yr (range, 11.9 to 13.6 yr) in patients with HMW and 11.9 yr (range, 10.8 to 13.1 yr) in patients with LMW apo(a) phenotypes (P = 0.2065). In patients who were 35 yr or younger at the time of transplantation, mean transplant survival was more than 3 yr longer in recipients with HMW apo(a) phenotypes compared with those with LMW apo(a) phenotypes (13.2 yr [range, 12.1 to 14.4 yr] versus 9.9 yr (range, 8.5 to 11.5 yr); P = 0.0156). In a Cox's proportional hazards regression model, the presence of LMW phenotypes-but not gender, immunosuppression, or HLA mismatches-in young patients was associated with a statistically significant risk of CR (P = 0.0434). These retrospective data indicate that young renal transplant recipients with LMW apo(a) phenotypes have a significantly shorter long-term graft survival, regardless of the number of HLA mismatches, gender, or immunosuppressive treatment.
Wahn
Friederike
F
University Children's Hospital, Charité, Berlin, Germany.
Daniel
Volker
V
Institute for Transplant Immunology, University of Heidelberg, Germany.
Kronenberg
Florian
F
Institute of Medical Biology and Human Genetics, University of Innsbruck, Innsbruck, Austria.
Opelz
Gerhard
G
Institute for Transplant Immunology, University of Heidelberg, Germany.
Michalk
Dietrich V
DV
University Children's Hospital, Cologne, Germany.
Querfeld
Uwe
U
University Children's Hospital, Charité, Berlin, Germany.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001054:Apolipoproteins A / Q000097:blood / Q000737:chemistry / Q000235:genetics*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006085:Graft Survival / Q000235:genetics / Q000276:immunology / Q000502:physiology; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D010641:Phenotype; D011110:Polymorphism, Genetic; D020033:Protein Isoforms / Q000097:blood / Q000737:chemistry / Q000235:genetics; D012189:Retrospective Studies; D013997:Time Factors
D001054:Apolipoproteins A; D020033:Protein Isoforms